Congestive heart failure morphine

Butorphanol tartrate (stadol) is better suited for the relief of acute than chronic pain. Because of its side effects on the heart, it is less useful than morphine or meperidine in patients with congestive heart failure or myocardial infarction. The usual dose is 1-4 mg of the tartrate given intramuscularly or 0.5-2 mg given intravenously every 3-4 hours. A nasal formulation (STADOLNS) is available and has proven to be effective. 

C. Pulmonaiy edema resulting from congestive heart failure. Chemical-induced noncardiogenic pulmonary edema is notan indication for morphine therapy. 

Amantadine may exacerbate central nervous system effects in disorders. Dosages must be adjusted for patients with renal disease or congestive heart failure. Since amantadine interacts with morphine caution is required when these two drugs are administered together. 

---